Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy

International Journal of Pharmaceutics

Volumn 478, Issue 1, 2015, Pages 240-250

  Gao, Huile ^a   Zhang, Qianyu ^a   Yang, Yuting ^a   Jiang, Xinguo ^b   He, Qin ^a  

^a SICHUAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cell penetrating peptide; Non small cell lung carcinoma; Targeted drug delivery; Tumor homing

Indexed keywords

CELL PENETRATING PEPTIDE; COUMARIN 6; DOCETAXEL; DRUG CARRIER; DYE; ETHYLENE GLYCOL; NANOPARTICLE; POLY(ETHYLENEGLYCOL)POLY( EPSILON CAPROLACTONE); POLYCAPROLACTONE; R 8; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MACROGOL DERIVATIVE; POLYESTER; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENZYME MODIFICATION; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; INFRARED RADIATION; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; ORGAN DISTRIBUTION; TISSUE DISTRIBUTION; TUMOR SPHEROID; TUMOR VOLUME; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG EFFECTS; MALE; NEOPLASMS; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; NEOPLASMS; POLYESTERS; POLYETHYLENE GLYCOLS; TAXOIDS; TUMOR BURDEN;

EID: 84912571365     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.11.029     Document Type: Article

References (52)

1. L. Alberici, L. Roth, K.N. Sugahara, L. Agemy, V.R. Kotamraju, T. Teesalu, C. Bordignon, C. Traversari, G.P. Rizzardi, and E. Ruoslahti De novo design of a tumor-penetrating peptide Cancer Res. 73 2013 804 812
2. T.M. Allen Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2 2002 750 763
3. Y.H. Bae, and K. Park Targeted drug delivery to tumors: myths, reality and possibility J. Controlled Release 153 2011 198 205
4. A. Bandekar, C. Zhu, A. Gomez, M.Z. Menzenski, M. Sempkowski, and S. Sofou Masking and triggered unmasking of targeting ligands on liposomal chemotherapy selectively suppress tumor growth in vivo Mol. Pharm. 10 2013 152 160
5. C. Bechara, and S. Sagan Cell-penetrating peptides: 20 years later where do we stand? FEBS Lett. 587 2013 1693 1702
6. S. Bhattacharyya, R. Bhattacharya, S. Curley, M.A. McNiven, and P. Mukherjee Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis Proc. Natl. Acad. Sci. U. S. A. 107 2010 14541 14546
7. S. Biswas, P.P. Deshpande, F. Perche, N.S. Dodwadkar, S.D. Sane, and V.P. Torchilin Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer Cancer Lett. 335 2013 191 200
8. L. Brannon-Peppas, and J.O. Blanchette Nanoparticle and targeted systems for cancer therapy Adv. Drug Delivery Rev. 56 2004 1649 1659
9. M.E. Davis, Z.G. Chen, and D.M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discovery 7 2008 771 782
10. A.T. Florence Targeting nanoparticles: the constraints of physical laws and physical barriers J. Controlled Release 164 2012 115 124
11. C. Foged, and H.M. Nielsen Cell-penetrating peptides for drug delivery across membrane barriers Expert Opin. Drug Delivery 5 2008 105 117
12. S.B. Fonseca, M.P. Pereira, and S.O. Kelley Recent advances in the use of cell-penetrating peptides for medical and biological applications Adv. Drug Delivery Rev. 61 2009 953 964
13. S. Futaki, W. Ohashi, T. Suzuki, M. Niwa, S. Tanaka, K. Ueda, H. Harashima, and Y. Sugiura Stearylated arginine-rich peptides: a new class of transfection systems Bioconjugate Chem. 12 2001 1005 1011
14. H. Gao, S. Pan, Z. Yang, S. Cao, C. Chen, X. Jiang, S. Shen, Z. Pang, and Y. Hu A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein Biomaterials 32 2011 8669 8675
15. H. Gao, Z. Pang, S. Pan, S. Cao, Z. Yang, C. Chen, and X. Jiang Anti-glioma effect and safety of docetaxel-loaded nanoemulsion Arch. Pharmacal Res. 35 2012 333 341
16. H. Gao, J. Qian, S. Cao, Z. Yang, Z. Pang, S. Pan, L. Fan, Z. Xi, X. Jiang, and Q. Zhang Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles Biomaterials 33 2012 5115 5123
17. H. Gao, J. Qian, Z. Yang, Z. Pang, Z. Xi, S. Cao, Y. Wang, S. Pan, S. Zhang, W. Wang, X. Jiang, and Q. Zhang Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(epsilon-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy Biomaterials 33 2012 6264 6272
18. H. Gao, Z. Yang, S. Zhang, S. Cao, S. Shen, Z. Pang, and X. Jiang Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization Sci. Rep. 3 2013 2534
19. H. Gao, Z. Yang, S. Zhang, Z. Pang, Q. Liu, and X. Jiang Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays Acta Biomater. 10 2014 858 867
20. W. Gao, B. Xiang, T.T. Meng, F. Liu, and X.R. Qi Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides Biomaterials 34 2013 4137 4149
21. T.T. Goodman, C.P. Ng, and S.H. Pun 3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers Bioconjugate Chem. 19 2008 1951 1959
22. G. Gu, H. Xia, Q. Hu, Z. Liu, M. Jiang, T. Kang, D. Miao, Y. Tu, Z. Pang, Q. Song, L. Yao, H. Chen, X. Gao, and J. Chen PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy Biomaterials 34 2013 196 208
23. L. Guo, J. Ren, and X. Jiang Perspectives on brain-targeting drug delivery systems Curr. Pharm. Biotechnol. 13 2012 2310 2318
24. Q. Hu, G. Gu, Z. Liu, M. Jiang, T. Kang, D. Miao, Y. Tu, Z. Pang, Q. Song, L. Yao, H. Xia, H. Chen, X. Jiang, X. Gao, and J. Chen F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery Biomaterials 34 2013 1135 1145
25. T. Jiang, E.S. Olson, Q.T. Nguyen, M. Roy, P.A. Jennings, and R.Y. Tsien Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc. Natl. Acad. Sci. U. S. A. 101 2004 17867 17872
26. X. Jiang, X. Sha, H. Xin, X. Xu, J. Gu, W. Xia, S. Chen, Y. Xie, L. Chen, Y. Chen, and X. Fang Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel Biomaterials 34 2013 2969 2979
27. E. Kondo, K. Saito, Y. Tashiro, K. Kamide, S. Uno, T. Furuya, M. Mashita, K. Nakajima, T. Tsumuraya, N. Kobayashi, M. Nishibori, M. Tanimoto, and M. Matsushita Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems Nat. Commun. 3 2012 951
28. E. Koren, and V.P. Torchilin Cell-penetrating peptides: breaking through to the other side Trends Mol. Med. 18 2012 385 393
29. R. Kuai, W. Yuan, Y. Qin, H. Chen, J. Tang, M. Yuan, Z. Zhang, and Q. He Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes Mol. Pharm. 7 2010 1816 1826
30. T. Le Chevalier Non-small cell lung cancer: the challenges of the next decade Front. Oncol. 1 2011 29
31. Y. Liu, M. Ji, M.K. Wong, K.I. Joo, and P. Wang Enhanced therapeutic efficacy of iRGD-conjugated crosslinked multilayer liposomes for drug delivery Biomed. Res. Int. 2013 2013 378380
32. A. Lopez-Gonzalez, M.P. Ibeas, B. Cantos, and M. Provencio Surveillance of resected non-small cell lung cancer Clin. Transl. Oncol. 14 2012 721 725
33. A. Makovitzki, A. Fink, and Y. Shai Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides Cancer Res. 69 2009 3458 3463
34. K.M. McMahon, M. Volpato, H.Y. Chi, P. Musiwaro, K. Poterlowicz, Y. Peng, A.J. Scally, L.H. Patterson, R.M. Phillips, and C.W. Sutton Characterization of changes in the proteome in different regions of 3D multicell tumor spheroids J. Proteome Res. 11 2012 2863 2875
35. T. Nakamura, D. Yamazaki, J. Yamauchi, and H. Harashima The nanoparticulation by octaarginine-modified liposome improves alpha-galactosylceramide-mediated antitumor therapy via systemic administration J. Controlled Release 171 2013 216 224
36. E.S. Olson, T. Jiang, T.A. Aguilera, Q.T. Nguyen, L.G. Ellies, M. Scadeng, and R.Y. Tsien Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases Proc. Natl. Acad. Sci. U. S. A. 107 2010 4311 4316
37. J. Ou, W. Luan, J. Deng, R. Sa, and H. Liang AlphaV integrin induces multicellular radioresistance in human nasopharyngeal carcinoma via activating SAPK/JNK pathway PLoS One 7 2012 e38737
38. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760
39. F. Perche, N.R. Patel, and V.P. Torchilin Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model J. Controlled Release 164 2012 95 102
40. K. Porkka, P. Laakkonen, J.A. Hoffman, M. Bernasconi, and E. Ruoslahti A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo Proc. Natl. Acad. Sci. U. S. A. 99 2002 7444 7449
41. L. Roth, L. Agemy, V.R. Kotamraju, G. Braun, T. Teesalu, K.N. Sugahara, J. Hamzah, and E. Ruoslahti Transtumoral targeting enabled by a novel neuropilin-binding peptide Oncogene 31 2012 3754 3763
42. D. Sarko, B. Beijer, B.R. Garcia, E.M. Nothelfer, K. Leotta, M. Eisenhut, A. Altmann, U. Haberkorn, and W. Mier The pharmacokinetics of cell-penetrating peptides Mol. Pharm. 7 2010 2224 2231
43. V.A. Sethuraman, and Y.H. Bae TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors J. Controlled Release 118 2007 216 224
44. K.N. Sugahara, T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, D.R. Greenwald, and E. Ruoslahti Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 328 2010 1031 1035
45. T. Teesalu, K.N. Sugahara, V.R. Kotamraju, and E. Ruoslahti C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration Proc. Natl. Acad. Sci. U. S. A. 106 2009 16157 16162
46. Z. Tu, M. Volk, K. Shah, K. Clerkin, and J.F. Liang Constructing bioactive peptides with pH-dependent activities Peptides 30 2009 1523 1528
47. R. van der Meel, L.J. Vehmeijer, R.J. Kok, G. Storm, and E.V. van Gaal Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status Adv. Drug Delivery Rev. 65 2013 1284 1298
48. P.A. Wender, D.J. Mitchell, K. Pattabiraman, E.T. Pelkey, L. Steinman, and J.B. Rothbard The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. U. S. A. 97 2000 13003 13008
49. J. Wu, D. Wu, M.A. Mutschler, and C. Chu Cationic hybrid hydrogels from amino-acid-based poly(ester amide): fabrication, characterization, and biological properties Adv. Funct. Mater. 22 2012 3815 3823
50. Z. Yu, R.M. Schmaltz, T.C. Bozeman, R. Paul, M.J. Rishel, K.S. Tsosie, and S.M. Hecht Selective tumor cell targeting by the disaccharide moiety of bleomycin J. Am. Chem. Soc. 135 2013 2883 2886
51. Q. Zhang, J. Tang, L. Fu, R. Ran, Y. Liu, M. Yuan, and Q. He A pH-responsive alpha-helical cell penetrating peptide-mediated liposomal delivery system Biomaterials 34 2013 7980 7993
52. W. Zhang, J. Song, B. Zhang, L. Liu, K. Wang, and R. Wang Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells Bioconjugate Chem. 22 2011 1410 1415